Dr. Schandl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Education & Training
- Medical University of South CarolinaResidency, Pathology-Anatomic and Clinical, 1999 - 2004
- Medical University of South CarolinaFellowship, Forensic Pathology, 2001 - 2002
- Medical University of South CarolinaClass of 1999
Certifications & Licensure
- FL State Medical License 2002 - 2025
- NC State Medical License 2014 - 2025
- SC State Medical License 2001 - 2025
- IN State Medical License 2016 - 2017
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Forensic Pathology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- Reduced Likelihood of Hospitalization With the JN.1 or HV.1 Severe Acute Respiratory Syndrome Coronavirus 2 Variants Compared With the EG.5 Variant.Matthew E Levy, Vanessa Chilunda, Richard E Davis, Phillip R Heaton, Pamala A Pawloski
The Journal of Infectious Diseases. 2024-11-15 - 2 citationsNovel high-risk acute myeloid leukemia subgroup with ERG amplification and Biallelic loss of TP53.Cynthia A Schandl, Sandra Mazzoni, Iya Znoyko, Georges J Nahhas, Dongjun Chung
Cancer Genetics. 2023-04-01 - Liquid Biopsy for Advanced Cancer: An Amplicon-Based Massively Parallel Sequencing Panel Approach to Precision Oncology.Kristen Maurer, Cynthia A Schandl
Methods in Molecular Biology. 2023-01-01
Abstracts/Posters
- Clinical Utility of Chromosomal Microarray in Establishing Clonality and High Risk Features in Patients with Richter TransformationCynthia Schandl, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Title: SNP Microarray Reveals Predicted Outcomes of a Novel High Risk AML Subgroup with ERG AmplificationClinically Relevant AbstractCynthia Schandl, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: